Human placental stem cell-derived extracellular vesicles ameliorate loss of intestinal stem cell subtypes in experimental necrotizing enterocolitis
In the authors' words
Background: Necrotizing enterocolitis (NEC) is a devastating intestinal disease in premature infants with epithelial barrier disruption and loss of intestinal stem cells (ISCs). While depletion of active ISC (aISC) populations has been reported in NEC, the impact of NEC on reserve ISC (rISC) populations during early postnatal development remains poorly understood. We examined developmental and disease-associated changes in ISC subpopulations and evaluated the effects of human placental stem cell-derived extracellular vesicle (hPSC-EV) therapy on ISC preservation and recovery. Methods: Experimental NEC was induced in neonatal rat pups through exposure to NEC stressors with animals assigned as breastfed controls (BF), NEC, or NEC treated with hPSC-EVs (NEC-EV). Ileal tissue was assessed histologically and immunostained for SOX9, OLFM4, HOPX, BMI1, and Ki67. ISC populations were quantified across early postnatal development (32, 56, and 96 hours of life), during NEC progression, and with EV therapy. Results: NEC caused significant histological injury accompanied by marked reductions in SOX9+ and OLFM4+ cells, indicating early and sustained loss of aISC populations. Among rISC markers in established NEC, BMI1+ cells were preserved, whereas HOPX+ cells were significantly reduced. Assessment of healthy early postnatal development revealed that SOX9+ and OLFM4+ cell numbers remained relatively stable, while HOPX+ and BMI1+ populations significantly expanded and were predominantly proliferative. Early NEC did not initially deplete HOPX+ cells but prevented their normal developmental expansion, resulting in the observed reduction of HOPX+ cell abundance during established disease. Treatment with hPSC-EVs significantly improved intestinal architecture and restored SOX9+, OLFM4+, and HOPX+ cell populations to near-control levels. Conclusions: NEC differentially affects ISC subpopulations in the developing intestine, causing loss of aISC and disrupting the expansion of HOPX+ rISC. Preservation and restoration of both aISC and HOPX+ rISC populations may contribute to epithelial regeneration and recovery. These findings identify HOPX-associated development and regeneration as potential therapeutic targets and demonstrate that hPSC-derived extracellular vesicles support ISC recovery and intestinal repair in experimental NEC.
Appeared: Tuesday, November 17. bioRxiv. Preprint, not yet peer-reviewed.